Skip to Content
Merck
  • Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors.

Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors.

Bioorganic & medicinal chemistry (2012-03-02)
Claas Hundsdörfer, Hans-Jörg Hemmerling, Claudia Götz, Frank Totzke, Patrick Bednarski, Marc Le Borgne, Joachim Jose
ABSTRACT

Herein we describe the synthesis and properties of indeno[1,2-b]indole derivatives as a novel class of potent inhibitors of the human protein kinase CK2. A set of 19 compounds was obtained using a convenient and straightforward synthesis protocol. The compounds were tested for inhibition of human protein kinase CK2, which was recombinantly expressed in Escherichia coli. New inhibitors with IC(50) in the micro- and sub-micromolar range were identified. Compound 4b (5-isopropyl-7,8-dihydroindeno[1,2-b]indole-9,10(5H,6H)-dione) inhibited human CK2 with an IC(50) of 0.11 μM and did not significantly inhibit 22 other human protein kinases, suggesting selectivity towards CK2. ATP-competitive inhibition by compound 4b was shown and a K(i) of 0.06 μM was determined. Our findings indicate that indeno[1,2-b]indoles are a promising starting point for further development and optimization of human protein kinase CK2 inhibitors.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Emodin, from Frangula bark, ≥90% (HPLC)
Sigma-Aldrich
5,6-Dichlorobenzimidazole 1-β-D-ribofuranoside
Sigma-Aldrich
Ellagic acid, ≥95% (HPLC), powder, from tree bark